Bladder cancer risk and personal hair dye use

International Journal of Cancer

Volumn 109, Issue 4, 2004, Pages 581-586

  Andrew, Angeline S ^a   Schned, Alan R ^a   Heaney, John A ^a   Karagas, Margaret R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Bladder cancer; Case control; Hair dye; Logistic regression; Permanent dye

Indexed keywords

HAIR DYE;

ARTICLE; BLADDER CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HAIRDRESSER; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RISK REDUCTION;

ADULT; AGE DISTRIBUTION; AGED; CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HAIR DYES; HUMANS; INTERVIEWS; MALE; MIDDLE AGED; NEW HAMPSHIRE; OCCUPATIONAL EXPOSURE; ODDS RATIO; RISK FACTORS; SEX DISTRIBUTION; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 1542510117     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11729     Document Type: Article

References (52)

1. La Vecchia C, Tavani A. Epidemiological evidence on hair dyes and the risk of cancer in humans. Eur J Cancer Prev 1995;4:31-43.
2. Czene K, Tiikkaja S, Hemminki K. Cancer risks in hairdressers: assessment of carcinogenicity of hair dyes and gels. Int J Cancer 2003;105:108-12.
3. Hennekens CH, Speizer FE, Rosner B, Bain CJ, Belanger C, Peto R. Use of permanent hair dyes and cancer among registered nurses. Lancet 1979;1:1390-3.
4. Thun MJ, Altekruse SF, Namboodiri MM, Calle EE, Myers DG, Heath CW, Jr. Hair dye use and risk of fatal cancers in U.S. women. J Natl Cancer Inst 1994;86:210-5.
5. Altekruse SF, Henley SJ, Thun MJ. Deaths from hematopoietic and other cancers in relation to permanent hair dye use in a large prospective study (United States). Cancer Causes Control 1999;10:617-25.
6. Hartge P, Hoover R, Altman R, Austin DF, Cantor KP, Child MA, Key CR, Mason TJ, Marrett LD, Myers MH, Narayana AS, Silverman DT, et al. Use of hair dyes and risk of bladder cancer. Cancer Res 1982;42:4784-7.
7. Najem GR, Louria DB, Seebode JJ, Thind IS, Prusakowski JM, Ambrose RB, Fernicola AR. Life time occupation, smoking, caffeine, saccharine, hair dyes and bladder carcinogenesis. Int J Epidemiol 1982;11:212-7.
8. Stavraky KM, Clarke EA, Donner A. A case-control study of hair-dye use and cancers of various sites. Br J Cancer 1981;43:236-9.
9. Howe GR, Burch JD, Miller AB, Cook GM, Esteve J, Morrison B, Gordon P, Chambers LW, Fodor G, Winsor GM. Tobacco use, occupation, coffee, various nutrients, and bladder cancer. J Natl Cancer Inst 1980;64:701-13.
10. Nomura A, Kolonel LN, Yoshizawa CN. Smoking, alcohol, occupation, and hair dye use in cancer of the lower urinary tract. Am J Epidemiol 1989;130:1159-63.
11. Sullivan JW. Epidemiologic survey of bladder cancer in greater New Orleans. J Urol 1982;128:281-3.
12. Ohno Y, Aoki K, Obata K, Morrison AS. Case-control study of urinary bladder cancer in metropolitan Nagoya. Natl Cancer Inst Monogr 1985;69:229-34.
13. Gago-Dominguez M, Castelao JE, Yuan JM, Yu MC, Ross RK. Use of permanent hair dyes and bladder-cancer risk. Int J Cancer 2001;91:575-9.
14. Searle CE, Jones EL. Effects of repeated applications of two semi-permanent hair dyes to the skin of A and DBAf mice. Br J Cancer 1977;36:467-78.
15. Van Duuren BL. Carcinogenicity of hair dye components. J Environ Pathol Toxicol 1980;3:237-251.
16. Benedict WF. Morphological transformations and chromosome aberrations produced by two hair dye components. Nature 1976;260:368-9.
17. Silverman DT, Morrison AS, Devesa S.S. Bladder Cancer. In: Schottenfeld D, Fraumeni JF, eds. Cancer Epidemiology and Prevention. New York: Oxford University Press, 1996. 1156-79.
18. Ammenheuser MM, Warren ME. Detection of mutagens in the urine of rats following topical application of hair dyes. Mutat Res 1979;66:241-5.
19. Maibach HI, Leaffer MA, Skinner WA. Percutaneous penetration following use of hair dyes. Arch Dermatol 1975;111:1444-5.
20. Karagas MR, Stukel TA, Morris JS, Tosteson TD, Weiss JE, Spencer SK, Greenberg ER. Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am J Epidemiol 2001;153:559-65.
21. Karagas MR, Tosteson TD, Blum J, Morris JS, Baron JA, Klaue B. Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population. Environ Health Perspect 1998;106:1047-50.
22. Alderson M. Cancer mortality in male hairdressers. J Epidemiol Community Health 1980;34:182-5.
23. Kono S, Tokudome S, Ikeda M, Yoshimura T, Kuratsune M. Cancer and other causes of death among female beauticians. J Natl Cancer Inst 1983;70:443-6.
24. Teta MJ, Walrath J, Meigs JW, Flannery JT. Cancer incidence among cosmetologists. J Natl Cancer Inst 1984;72:1051-7.
25. Guberan E, Raymond L, Sweetnam PM. Increased risk for male bladder cancer among a cohort of male and female hairdressers from Geneva. Int J Epidemiol 1985;14:549-54.
26. Skov T, Andersen A, Malker H, Pukkala E, Weiner J, Lynge E. Risk for cancer of the urinary bladder among hairdressers in the Nordic countries. Am J Ind Med 1990;17:217-23.
27. Pukkala E, Nokso-Koivisto P, Roponen P. Changing cancer risk pattern among Finnish hairdressers. Int Arch Occup Environ Health 1992;64:39-42.
28. Hrubec Z, Blair AE, Rogot E, Vaught J. Mortality risks by occupation among US veterans of known smoking status 1954-1980. NIH Publication No. 92-3407 1. Bethesda, MD, National Institutes of Health, 1992.
29. Wynder EL, Onderdonk J, Mantel N. An epidemiological investigation of cancer of the bladder. Cancer 1963;71:1388-407.
30. Dunham LJ, Rabson AS, Stewart HL, Frank AS, Young JL. Rates, interview, and pathology study of cancer of the urinary bladder in New Orleans, Louisiana. J Natl Cancer Inst 1968;41:683-709.
31. Anthony HM, Thomas GM. Tumors of the urinary bladder: an analysis of the occupations of 1,030 patients in Leeds, England. J Natl Cancer Inst 1970;45:879-95.
32. Cole P, Hoover R, Friedell GH. Occupation and cancer of the lower urinary tract. Cancer 1972;29:1250-60.
33. Viadana E, Bross ID, Houten L. Cancer experience of men exposed to inhalation of chemicals or to combustion products. J Occup Med 1976;18:787-92.
34. Vineis P, Magnani C. Occupation and bladder cancer in males: a case-control study. Int J Cancer 1985;35:599-606.
35. Morrison AS, Ahlbom A, Verhoek WG, Aoki K, Leck I, Ohno Y, Obata K. Occupation and bladder cancer in Boston, USA, Manchester, UK, and Nagoya, Japan. J Epidemiol Community Health 1985;39:294-300.
36. Risch HA, Burch JD, Miller AB, Hill GB, Steele R, Howe GR. Occupational factors and the incidence of cancer of the bladder in Canada. Br J Ind Med 1988;45:361-7.
37. Silverman DT, Levin LI, Hoover RN, Hartge P. Occupational risks of bladder cancer in the United States: I. White men. J Natl Cancer Inst 1989;81:1472-80.
38. Silverman DT, Levin LI, Hoover RN. Occupational risks of bladder cancer among white women in the United States. Am J Epidemiol 1990;132:453-61.
39. IARC working group on the evaluation of carcinogenic risks to humans: occupational exposures of hairdressers and barbers and personal use of hair colourants; some hair dyes, cosmetic colourants, industrial dyestuffs and aromatic amines. Proceedings. Lyon, France, 6-13 October 1992. IARC Monogr Eval Carcinog Risks Hum 1993;57:7-398.
40. Burnett CM, Goldenthal EI. Multigeneration reproduction and carcinogenicity studies in Sprague-Dawley rats exposed topically to oxidative hair-colouring formulations containing p-phenylenediamine and other aromatic amines. Food Chem Toxicol 1988;26:467-74.
41. Majeska JB, Holden HE. Genotoxic effects of p-aminophenol in Chinese hamster ovary and mouse lymphoma cells: results of a multiple endpoint test. Environ Mol Mutagen 1995;26:163-70.
42. Howes D, Black JG. Percutaneous absorption of 2-nitro-p-phenelyendiamine. Int J Cosmet Sci 1983;5:215-26.
43. Wolfram LJ, Maibach HI. Percutaneous penetration of hair dyes. Arch Dermatol Res 1985;277:235-41.
44. Yourick JJ, Bronaugh RL. Percutaneous penetration and metabolism of 2-nitro-p-phenylenediamine in human and fuzzy rat skin. Toxicol Appl Pharmacol 2000;166:13-23.
45. Marshall S, Palmer WS. Letter: Dark urine after hair coloring. JAMA 1973;226:1010.
46. Kiese M, Rauscher E. The absorption of p-toluenediamine through human skin in hair dyeing. Toxicol Appl Pharmacol 1968;13:325-31.
47. SEER Cancer Statistics Review, 1973-1999. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK, eds. 2002. Bethesda, MD, National Cancer Institute.
48. Gago-Dominguez M, Chan KK, Ross RK, Yu MC. Permanent hair dyes and bladder cancer risk. Int J Cancer 2001;94:905-6.
49. Kawakubo Y, Merk HF, Masaoudi TA, Sieben S, Blomeke B. N-Acetylation of paraphenylenediamine in human skin and keratinocytes. J Pharmacol Exp Ther 2000;292:150-5.
50. Cartwright RA, Glashan RW, Rogers HJ, Ahmad RA, Barham-Hall D, Higgins E, Kahn MA. Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet 1982;2:842-5.
51. Green J, Banks E, Berrington A, Darby S, Deo H, Newton R. N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction. Br J Cancer 2000;83:412-417.
52. Marcus PM, Hayes RB, Vineis P, Garcia-Closas M, Caporaso NE, Autrup H, Branch RA, Brockmoller J, Ishizaki T, Karakaya AE, Ladero JM, Mommsen S, et al. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol Biomarkers Prev 2000;9:461-7.